FDA Adverse Event Injury Summary report: N

GORE® CARDIOFORM ASD OCCLUDER

MDR report key: 9480798 · Received December 17, 2019

Report

Report Number
2017233-2019-01250
Event Type
Injury
Date Received
December 17, 2019
Date of Event
November 21, 2019
Report Date
January 22, 2020
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
MLV
UDI-DI
00733132636488
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL CASE DETAILS: STATIC DEFECT MEASUREMENT WAS 10MM; THE PATIENT HAD A DEFICIENT AORTIC RIM (>5MM); THERE WAS A SUFFICIENT POSTERIOR RIM (NO MEASUREMENTS). THE GORE® CARDIOFORM ASD OCCLUDER INSTRUCTIONS FOR USE LIST EMBOLIZATION AS POTENTIAL CLINICAL AND DEVICE ADVERSE EVENT.

Additional Manufacturer Narrative · 1

PMA/510(K) # :P050006.

Description of Event or Problem · 1

IT WAS REPORTED THE PHYSICIAN IMPLANTED A 27MM GORE® CARDIOFORM ASD OCCLUDER TO CLOSE AN ATRIAL SEPTAL DEFECT ON (B)(6) 2019. THE DEFECT WAS NOT BALLOON SIZED. TRANSTHORACIC ECHOCARDIOGRAPHY ON (B)(6) 2019 SHOWED THE DEVICE HAD EMBOLIZED TO THE LEFT PULMONARY ARTERY. THE EMBOLIZED DEVICE WAS REMOVED BY SNARE IN A TRANSCATHETER PROCEDURE AND A 32MM GORE® CARDIOFORM ASD OCCLUDER WAS IMPLANTED. THE PATIENT IS CURRENTLY STABLE AND DOING WELL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1274545 GORE® CARDIOFORM ASD OCCLUDER TRANSCATHETER, SEPTAL OCCLUDER MLV W.L. GORE & ASSOCIATES ASD27A 20858365 00733132636488

Patients

Seq Age Sex Outcome Treatment
1 3 YR Required Intervention